MLYS

Mineralys Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Rodman David MalcomChief Medical Officer
$235k9.9k shares
SellJun 15, 2026
$23.81
$25.13
Rodman David MalcomChief Medical Officer
$115k4.6k shares
SellJun 17, 2026
$25.00
$25.13
Karydas DaphneDirector
$75k3k shares
SellJun 17, 2026
$25.00
$25.13
Rodman David MalcomChief Medical Officer
$205k6.3k shares
SellJan 12, 2026
$32.32
--
Levy Adam ScottCFO And Secretary
$346k10.8k shares
SellJan 12, 2026
$32.14
--
Congleton JonDirector, Officer: Chief Executive Officer
$236k7.1k shares
SellJan 12, 2026
$33.15
--

News

globenewswire.comMineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)globenewswire.comJun 14seekingalpha.comMineralys Therapeutics, Inc. (MLYS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 11globenewswire.comMineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conferenceglobenewswire.comJun 8globenewswire.comMineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conferenceglobenewswire.comJun 8globenewswire.comMineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)globenewswire.comJun 8